Feb 17 |
We're Keeping An Eye On Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Rate
|
Feb 15 |
Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-1664
|
Feb 13 |
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
|
Feb 13 |
Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?
|
Feb 12 |
Repare to regain global rights to camonsertib from Roche
|
Feb 12 |
Repare Therapeutics to Regain Global Rights to Camonsertib
|
Feb 1 |
Biogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
|
Jan 25 |
Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment
|
Jan 8 |
Repare Therapeutics Provides Corporate Update and Highlights Anticipated Key 2024 Milestones
|
Jan 4 |
Repare Therapeutics and Debiopharm Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer
|